|
ECOG-EA4232
Phase III
OPEN TO ACCRUAL
|
|
ECOG-EA7222
Phase III
OPEN TO ACCRUAL
|
|
LILLY-J2N-MC-JZNY
Phase IV
OPEN TO ACCRUAL
|
|
SWOG-MM1YA-S01
Phase II
OPEN TO ACCRUAL
|
| |
|
1
| |
|
1
| |
1
| |
2
| |
|
|
| |
1
| |
|
2
| |
| |
|
1
| |
6
| |
CELGENE-GC-LTFU-001
Phase II/III
OPEN TO ACCRUAL
| |
GRACELL-GC012F-CD19-BCMA-001
Phase I/II
OPEN TO ACCRUAL
| |
GSK-3377794-LTFU
Phase I
OPEN TO ACCRUAL
| |
IIT-SHAH-IL7-IL15-CD20-19
Phase I/II
OPEN TO ACCRUAL
| |
JNJ-MY4002-CARTINUE-LTFU
Phase IV
OPEN TO ACCRUAL
| |
JUNO-017004-TRANSCEND-CLL
Phase I/II
OPEN TO ACCRUAL
|
|
| |
| |
1
| |
1
| |
|
1
|
|
| |
| |
| |
|
3
|
| |
1
| |
|
1
| |
|
|
1
|
3
| |
2
| |
|
1
| |
|
| |
3
|
|
| |
2
|
| |
|
|
2
| |
2
|
| |
1
| |
|
1
| |
|
1
|
|
| |
| |
|
|
|
|
4
| |
4
|
1
| |
1
| |
4
|
5
| |
1
| |
1
| |
|
1
| |
|
| |
|
4
| |
1
| |
|
1
|
| |
2
| |
| |
|
|
| |
1
| |
|
1
| |
|
1
| |
3
| |
1
| |
IIT-GEORGE-I-PREDICT
Phase I/II
OPEN TO ACCRUAL
|
|
1
| |
ALLIANCE-A151804
Phase N/A
OPEN TO ACCRUAL
|
|